| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Champions Oncology, Inc. is dedicated to developing and commercializing cutting-edge technological products and services designed to personalize cancer treatment and streamline the development of oncology drugs across the United States. At the heart of its offerings is the Tumorgraft Technology Platform, an innovative approach that facilitates individualized cancer care by implanting human tumors into immune-deficient mice. Utilizing this proprietary platform, the company not only delivers personalized cancer solutions directly but also …
Over the last 12 months, insiders at Champions Oncology, Inc. have bought $0 and sold $0 worth of Champions Oncology, Inc. stock.
On average, over the past 5 years, insiders at Champions Oncology, Inc. have bought $245,869 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,000 shares for transaction amount of $6,500 was made by Mendelson Daniel Newman (director) on 2024‑01‑12.
| 2024-01-12 | Mendelson Daniel Newman | director | 1,000 0.0071% | $6.50 | $6,500 | -27.12% | ||
| 2024-01-11 | Mendelson Daniel Newman | director | 2,000 0.0147% | $6.27 | $12,540 | -21.18% | ||
| 2024-01-10 | Mendelson Daniel Newman | director | 2,944 0.022% | $6.31 | $18,577 | -20.33% | ||
| 2024-01-09 | Mendelson Daniel Newman | director | 3,000 0.0221% | $6.25 | $18,750 | -21.47% | ||
| 2024-01-08 | Mendelson Daniel Newman | director | 1,000 0.0074% | $6.15 | $6,150 | -20.20% | ||
| 2024-01-05 | Mendelson Daniel Newman | director | 2,000 0.0146% | $6.09 | $12,180 | -19.22% | ||
| 2024-01-04 | Mendelson Daniel Newman | director | 3,000 0.0221% | $6.12 | $18,360 | -19.67% | ||
| 2024-01-03 | Mendelson Daniel Newman | director | 500 0.0035% | $5.83 | $2,915 | -20.33% | ||
| 2023-12-21 | Mendelson Daniel Newman | director | 2,500 0.0184% | $4.92 | $12,300 | -0.20% | ||
| 2023-12-20 | Mendelson Daniel Newman | director | 2,100 0.015% | $4.82 | $10,122 | -1.41% | ||
| 2023-12-19 | Mendelson Daniel Newman | director | 5,000 0.0384% | $4.75 | $23,750 | +7.46% | ||
| 2023-10-11 | Mendelson Daniel Newman | director | 5,000 0.0385% | $6.40 | $32,000 | -18.72% | ||
| 2023-10-10 | Mendelson Daniel Newman | director | 1,100 0.008% | $6.41 | $7,051 | -21.44% | ||
| 2023-10-06 | Mendelson Daniel Newman | director | 1,530 0.0114% | $6.48 | $9,914 | -22.02% | ||
| 2023-10-05 | Mendelson Daniel Newman | director | 2,000 0.0156% | $6.47 | $12,940 | -18.87% | ||
| 2023-10-04 | Mendelson Daniel Newman | director | 5,000 0.0386% | $6.40 | $32,000 | -20.16% | ||
| 2023-10-03 | Mendelson Daniel Newman | director | 2,500 0.019% | $6.30 | $15,750 | -19.75% | ||
| 2023-09-29 | Mendelson Daniel Newman | director | 4,000 0.0294% | $6.16 | $24,640 | -18.68% | ||
| 2023-09-28 | Mendelson Daniel Newman | director | 5,000 0.0379% | $6.22 | $31,100 | -16.94% | ||
| 2023-09-27 | Mendelson Daniel Newman | director | 1,500 0.0115% | $5.95 | $8,925 | -12.63% |
| BROWN MICHAEL MAURICE | 10 percent owner | 22281040 160.0814% | $107.62M | 2 | 0 | |
| Battery Ventures IX, L.P. | 10 percent owner | 22281040 160.0814% | $107.62M | 2 | 0 | |
| ACKERMAN JOEL | director | 1021731 7.3408% | $4.93M | 10 | 1 | +66.05% |
| Morris Ronnie | CEO | 858878 6.1707% | $4.15M | 16 | 1 | +86.37% |
| Mendelson Daniel Newman | director | 198625 1.4271% | $959,358.75 | 30 | 2 | <0.0001% |
| BURKETT DOUGLAS D | President | 850 0.0061% | $4,105.50 | 3 | 0 |
$5,831,763 | 118 | -33.78% | $66.68M | |
$9,405,928 | 107 | 12.61% | $74.85M | |
$17,525,882 | 60 | 5.22% | $64.7M | |
$19,705,388 | 47 | 86.26% | $67.15M | |
Champions Oncology, Inc. (CSBR) | $909,129 | 37 | 42.19% | $67.23M |
| Increased Positions | 10 | +31.25% | 154,844 | +2.7% |
| Decreased Positions | 11 | -34.38% | 129,728 | -2.27% |
| New Positions | 3 | New | 98,744 | New |
| Sold Out Positions | 4 | Sold Out | 105,251 | Sold Out |
| Total Postitions | 31 | -3.13% | 6M | +0.44% |
| Battery Management Corp. | $16,128.00 | 17.3% | 2.42M | 0 | 0% | 2025-09-30 |
| Nea Management Company, Llc | $11,413.00 | 12.24% | 1.71M | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $2,219.00 | 2.38% | 333,258 | +6,229 | +1.91% | 2025-09-30 |
| Tocqueville Asset Management L.P. | $2,129.00 | 2.28% | 319,674 | -80,208 | -20.06% | 2025-09-30 |
| Morgan Stanley | $1,263.00 | 1.35% | 189,600 | +59,100 | +45.29% | 2025-09-30 |
| Renaissance Technologies Llc | $1,114.00 | 1.2% | 167,261 | -13,778 | -7.61% | 2025-09-30 |
| Blackrock, Inc. | $812.00 | 0.87% | 121,910 | +1,081 | +0.9% | 2025-09-30 |
| Geode Capital Management, Llc | $496.00 | 0.53% | 74,409 | -776 | -1.03% | 2025-09-30 |
| Northern Trust Corp | $309.00 | 0.33% | 46,434 | -7,328 | -13.63% | 2025-09-30 |
| Acadian Asset Management Llc | $241.00 | 0.26% | 36,182 | 0 | 0% | 2025-09-30 |